Global Leadership Initiative on Malnutrition-defined malnutrition coexisting with visceral adiposity predicted worse long-term all-cause mortality among inpatients with decompensated cirrhosis
- PMID: 39333477
- PMCID: PMC11436742
- DOI: 10.1038/s41387-024-00336-9
Global Leadership Initiative on Malnutrition-defined malnutrition coexisting with visceral adiposity predicted worse long-term all-cause mortality among inpatients with decompensated cirrhosis
Abstract
Background/objectives: Malnutrition coexisting with abdominal adipose tissue accumulation bring a double burden on prognosis. More recently, the Global Leadership Initiative on Malnutrition (GLIM) has reached a novel consensus concerning the diagnostic criteria, that is, a two-step modality combining nutritional risk screening and subsequent phenotypic/etiologic parameters for comprehensive evaluation in hopes of harmonizing the malnutrition diagnosis. We aimed to elucidate their synergistic impact among inpatients with decompensated cirrhosis concerning long-term mortality.
Subjects/methods: Malnutrition, visceral obesity, and visceral adiposity were defined by the Global Leadership Initiative on Malnutrition (GLIM), visceral fat area (VFA), and visceral to subcutaneous adipose tissue area ratio (VSR) on computed tomography, respectively. Accordingly, the patients were categorized into different groups given their nutritional status and visceral obesity/adiposity. Multivariate Cox regression was performed to identify independent risk factors associated with 1-year all-cause mortality. Kaplan-Meier curves with log-rank tests were compared among distinct groups.
Results: Totally, 295 patients were recruited. GLIM, VFA, and VSR identified 131 (44.4%), 158 (53.6%), and 59 (20%) patients with malnutrition, visceral obesity and visceral adiposity, respectively. Malnutrition coexisted with visceral obesity in 55 (MO group) relative to visceral adiposity in 40 patients (MA group). Multivariate Cox analysis showed that MA (hazard ratio: 2.48; 95% confidence interval: 1.06, 5.79; P = 0.036) was independently associated with dire outcome rather than MO. Moreover, patients with cirrhosis in the MA group had the worst survival status when compared with other groups (log-rank test: P < 0.001).
Conclusions: The current study indicated that coexisting GLIM-defined malnutrition and VSR-defined visceral adiposity were in relation to worse long-term mortality among inpatients. It is imperative to delicately manage nutritional status and provide personalized treatment in this vulnerable subgroup for achieving better prognosis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Development and external validation of Global Leadership Initiative on Malnutrition-dictated nomograms predicting long-term mortality in hospitalized patients with cirrhosis.Sci Prog. 2025 Jan-Mar;108(1):368504251320157. doi: 10.1177/00368504251320157. Sci Prog. 2025. PMID: 39967253 Free PMC article.
-
Coexistent GLIM-Defined Malnutrition and Sarcopenia Increase the Long-Term Mortality Risk in Hospitalized Patients with Decompensated Cirrhosis.Ann Nutr Metab. 2023;79(5):423-433. doi: 10.1159/000534152. Epub 2023 Sep 19. Ann Nutr Metab. 2023. PMID: 37725950
-
Body fat distribution is more predictive of all-cause mortality than overall adiposity.Diabetes Obes Metab. 2018 Jan;20(1):141-147. doi: 10.1111/dom.13050. Epub 2017 Aug 11. Diabetes Obes Metab. 2018. PMID: 28671751
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Association of Global Leadership Initiative on Malnutrition with survival outcomes in patients with cancer: A systematic review and meta-analysis.Clin Nutr. 2022 Sep;41(9):1874-1880. doi: 10.1016/j.clnu.2022.07.007. Epub 2022 Jul 12. Clin Nutr. 2022. PMID: 35944293
Cited by
-
Association of waist-to-height ratio with all-cause and obesity-related mortality in adults: a prospective cohort study.Front Nutr. 2025 Aug 11;12:1614347. doi: 10.3389/fnut.2025.1614347. eCollection 2025. Front Nutr. 2025. PMID: 40860487 Free PMC article.
References
-
- Eslam M, Sanyal AJ, George J. International Consensus P. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158:1999–2014.e1. - PubMed
-
- Hui Y, Cui B, Wang X, Sun M, Li Y, Yang W, et al. Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension Cirrhosis. 2022;1:42–56.
-
- Fukuda T, Bouchi R, Takeuchi T, Tsujimoto K, Minami I, Yoshimoto T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc Diabetol. 2018;17:55. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical